Huberman explains how stimulants like Adderall, Vyvanse, Ritalin and modafinil treat ADHD, plus their short- and long-term risks.

Andrew Huberman — Professor of neurobiology and ophthalmology at Stanford School of Medicine and host of the Huberman Lab podcast. This is a solo episode with no guest.
In this solo episode, Andrew Huberman breaks down the neuroscience of ADHD and the stimulant and non-stimulant drugs used to treat it. He explains how the prefrontal cortex acts as an 'orchestra conductor' that fails to properly coordinate brain networks in ADHD, and how Adderall, Vyvanse, Ritalin, dexedrine, modafinil and guanfacine work at the level of dopamine and norepinephrine. He addresses the central paradox of why giving stimulants calms hyperactive children, and reviews the literature on long-term effects including addiction, psychosis, height, cardiovascular and hormone health. Throughout he stresses correct diagnosis, minimal effective dosing under a board-certified psychiatrist, and the dangers of recreational or unprescribed use.